Related Experiment Video
Updated: Jun 21, 2026
07:27
How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
B-type natriuretic levels in critically ill patients: critically misleading?
1Department of Medicine, Baylor College of Medicine, 6620 Main Street, 11A,08, Houston, TX 77030, USA. hishamd@bcm.edu
Critical Care (London, England)
|August 12, 2009
Summary
B-type natriuretic peptide (BNP) is not reliable for diagnosing heart failure in critically ill patients. However, BNP and N-terminal pro-BNP may offer valuable prognostic insights for this vulnerable group.
Area of Science:
- Cardiology
- Critical Care Medicine
- Biomarker Research
Background:
- B-type natriuretic peptide (BNP) is widely used for diagnosing heart failure.
- Its utility in critically ill patients, especially with brain hemorrhage, is debated.
- N-terminal pro-BNP (NT-proBNP) is another commonly measured cardiac peptide.
Discussion:
- BNP and NT-proBNP show poor specificity for diagnosing systolic or diastolic heart failure in the critically ill.
- Elevated levels in this population may be influenced by non-cardiac factors.
- The diagnostic accuracy of these biomarkers is limited in complex critical care scenarios.
Key Insights:
- BNP and NT-proBNP levels are not recommended for the primary diagnosis of heart failure in critically ill patients.
- These biomarkers lack the specificity required for accurate diagnosis in this setting.
- Poor specificity is a significant limitation for diagnostic use.
Outlook:
- Cardiac peptides like BNP and NT-proBNP show potential as prognostic markers in critically ill patients.
- Further research is needed to establish their role in predicting outcomes.
- Investigating their prognostic value could improve patient management and risk stratification.
Related Concept Videos
01:22Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...